Acute Simvastatin Inhibits KATP Channels of Porcine Coronary Artery Myocytes
Authors:
Open Access
- 17 June 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (6) , e66404
Abstract
Statins (3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase inhibitors) consumption provides beneficial effects on cardiovascular systems. However, effects of statins on vascular KATP channel gatings are unknown. Pig left anterior descending coronary artery and human left internal mammary artery were isolated and endothelium-denuded for tension measurements and Western immunoblots. Enzymatically-dissociated/cultured arterial myocytes were used for patch-clamp electrophysiological studies and for [Ca2+]i, [ATP]i and [glucose]o uptake measurements. The cromakalim (10 nM to 10 µM)- and pinacidil (10 nM to 10 µM)-induced concentration-dependent relaxation of porcine coronary artery was inhibited by simvastatin (3 and 10 µM). Simvastatin (1, 3 and 10 µM) suppressed (in okadaic acid (10 nM)-sensitive manner) cromakalim (10 µM)- and pinacidil (10 µM)-mediated opening of whole-cell KATP channels of arterial myocytes. Simvastatin (10 µM) and AICAR (1 mM) elicited a time-dependent, compound C (1 µM)-sensitive [3H]-2-deoxy-glucose uptake and an increase in [ATP]i levels. A time (2–30 min)- and concentration (0.1–10 µM)-dependent increase by simvastatin of p-AMPKα-Thr172 and p-PP2A-Tyr307 expression was observed. The enhanced p-AMPKα-Thr172 expression was inhibited by compound C, ryanodine (100 µM) and KN93 (10 µM). Simvastatin-induced p-PP2A-Tyr307 expression was suppressed by okadaic acid, compound C, ryanodine, KN93, phloridzin (1 mM), ouabain (10 µM), and in [glucose]o-free or [Na+]o-free conditions. Simvastatin causes ryanodine-sensitive Ca2+ release which is important for AMPKα-Thr172 phosphorylation via Ca2+/CaMK II. AMPKα-Thr172 phosphorylation causes [glucose]o uptake (and an [ATP]i increase), closure of KATP channels, and phosphorylation of AMPKα-Thr172 and PP2A-Tyr307 resulted. Phosphorylation of PP2A-Tyr307 occurs at a site downstream of AMPKα-Thr172 phosphorylation.Keywords
This publication has 62 references indexed in Scilit:
- Survival of Cancer Stem Cells under Hypoxia and Serum Depletion via Decrease in PP2A Activity and Activation of p38-MAPKAPK2-Hsp27PLOS ONE, 2012
- Statins and Selective Inhibition of Rho Kinase Protect Small Conductance Calcium-Activated Potassium Channel Function (KCa2.3) in Cerebral ArteriesPLOS ONE, 2012
- Acute simvastatin increases endothelial nitric oxide synthase phosphorylation via AMP-activated protein kinase and reduces contractility of isolated rat mesenteric resistance arteriesClinical Science, 2011
- Regulation of Rac1 by Simvastatin in Endothelial CellsJournal of Biological Chemistry, 2009
- AMP-activated protein kinase and hypoxic pulmonary vasoconstrictionEuropean Journal of Pharmacology, 2008
- Reactive Nitrogen Species Is Required for the Activation of the AMP-activated Protein Kinase by Statin in VivoJournal of Biological Chemistry, 2008
- LKB1 and AMPK and the regulation of skeletal muscle metabolismCurrent Opinion in Clinical Nutrition and Metabolic Care, 2008
- Modulation by simvastatin of iberiotoxin‐sensitive, Ca2+‐activated K+ channels of porcine coronary artery smooth muscle cellsBritish Journal of Pharmacology, 2007
- Activation of AMP kinase α1 subunit induces aortic vasorelaxation in miceThe Journal of Physiology, 2007
- Regulation of the mevalonate pathwayNature, 1990